Effects of Rosiglitazone on the Metabolic Phenotype of Impaired Glucose Tolerance in Youth
Phase of Trial: Phase II
Latest Information Update: 19 Jul 2013
At a glance
- Drugs Rosiglitazone (Primary)
- Indications Glucose intolerance
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 13 May 2010 Results published in Obesity.
- 19 Jan 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.